US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist

0.2112
+0.0076+3.73%

Close Jul 25 16:00 ET

0.2053
-0.0059-2.79%

Post 20:02 ET

4.95MMarket Cap-480P/E (TTM)

ReShape Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

59.06%-2.07M

22.56%-16.96M

13.15%-2.46M

47.28%-2.78M

-3.74%-6.66M

31.40%-5.06M

-42.45%-21.9M

17.43%-2.83M

32.40%-5.27M

-193.51%-6.42M

Net income from continuing operations

17.62%-2.19M

75.36%-11.39M

89.69%-1.7M

71.00%-3.53M

63.01%-3.49M

67.20%-2.66M

26.81%-46.21M

55.09%-16.47M

31.15%-12.19M

-142.03%-9.44M

Operating gains losses

99.29%-21K

-839.32%-3.91M

-119.18%-28K

-20,700.00%-412K

---506K

---2.97M

-89.15%529K

--146K

-99.93%2K

----

Depreciation and amortization

-87.50%6K

-92.85%154K

-98.64%7K

-90.79%50K

-91.01%49K

-91.27%48K

9.23%2.15M

-7.21%515K

-0.91%543K

21.11%545K

Deferred tax

200.00%1K

106.62%28K

149.09%27K

100.54%2K

--0

---1K

-70.56%-423K

77.82%-55K

---368K

--0

Other non cash items

-99.67%1K

173.91%17K

-14,550.00%-293K

--0

350.00%9K

1,605.00%301K

-103.67%-23K

-111.76%-2K

-113.04%-3K

-96.97%2K

Change In working capital

1,065.96%454K

-683.07%-4.13M

-174.53%-761K

80.16%-218K

-321.53%-3.11M

92.37%-47K

126.14%709K

197.67%1.02M

74.79%-1.1M

-1.20%1.4M

-Change in receivables

1,995.24%440K

-81.56%125K

2,504.76%547K

-359.14%-482K

-57.61%39K

-94.46%21K

338.73%678K

-96.59%21K

553.66%186K

216.46%92K

-Change in inventory

196.30%320K

60.83%-465K

-693.85%-772K

-11.43%31K

160.22%168K

110.07%108K

-221.68%-1.19M

133.33%130K

107.61%35K

-193.31%-279K

-Change in prepaid assets

87.12%-47K

-115.07%-172K

-64.72%157K

-58.89%141K

-121.43%-105K

-166.42%-365K

1,601.32%1.14M

37.77%445K

359.85%343K

197.22%490K

-Change in payables and accrued expense

-175.29%-259K

-871.65%-3.46M

-238.88%-693K

104.45%69K

-352.14%-3.18M

43.33%344K

135.00%448K

-10.57%499K

57.98%-1.55M

-19.08%1.26M

-Change in other current liabilities

--0

50.94%-182K

--0

95.54%-5K

79.38%-33K

-476.00%-144K

47.23%-371K

79.21%-74K

12.50%-112K

5.33%-160K

-Change in other working capital

----

--17K

--0

--28K

--0

---11K

----

Cash from discontinued investing activities

Operating cash flow

59.06%-2.07M

22.56%-16.96M

13.15%-2.46M

47.28%-2.78M

-3.74%-6.66M

31.40%-5.06M

-42.45%-21.9M

17.43%-2.83M

32.40%-5.27M

-193.51%-6.42M

Investing cash flow

Cash flow from continuing investing activities

89.13%-10K

-116.67%-3K

-450.00%-7K

-104.96%-92K

97.42%-79K

62.92%-33K

-99.65%18K

Capital expenditure reported

--0

67.18%-43K

--0

-200.00%-36K

0.00%-7K

62.78%-131K

-17.91%-79K

62.92%-33K

84.42%-12K

Net PPE purchase and sale

----

-15.38%33K

--0

----

--39K

--0

--30K

Cash from discontinued investing activities

Investing cash flow

--0

89.13%-10K

--0

-116.67%-3K

-450.00%-7K

-104.96%-92K

97.42%-79K

62.92%-33K

-99.65%18K

Financing cash flow

Cash flow from continuing financing activities

461.47%17.57M

755.96%5.46M

-11,366.67%-338K

-9.60%2.25M

10.2M

-90.60%3.13M

638K

100.10%3K

-92.96%2.49M

Net common stock issuance

--0

----

--10.2M

----

Proceeds from stock option exercised by employees

----

66.04%4.14M

413,700.00%4.14M

--0

----

-94.59%2.49M

---1K

-98.51%3K

----

Net other financing activities

----

2,002.97%13.44M

--13.78M

---12.79M

----

119.76%639K

----

Cash from discontinued financing activities

Financing cash flow

--0

461.47%17.57M

755.96%5.46M

-11,366.67%-338K

-9.60%2.25M

--10.2M

-90.60%3.13M

--638K

100.10%3K

-92.96%2.49M

Net cash flow

Beginning cash position

15.27%4.56M

-82.66%3.96M

-75.20%1.55M

-59.57%4.67M

-41.25%9.08M

-82.66%3.96M

658.73%22.82M

-78.68%6.25M

-71.29%11.54M

694.45%15.46M

Current changes in cash

-140.37%-2.07M

103.20%604K

232.33%3M

41.20%-3.12M

-12.77%-4.42M

169.59%5.13M

-195.37%-18.86M

65.04%-2.27M

51.45%-5.3M

-110.23%-3.92M

Effect of exchange rate changes

-60.00%-8K

--0

130.00%6K

--0

0.00%-1K

-123.81%-5K

-86.21%4K

-233.33%-20K

100.00%4K

85.71%-1K

End cash Position

-72.71%2.48M

15.27%4.56M

-75.20%1.55M

-59.57%4.67M

-41.25%9.08M

-82.66%3.96M

-78.68%6.25M

-71.29%11.54M

Free cash flow

59.12%-2.07M

22.83%-17M

15.51%-2.46M

47.61%-2.78M

-4.10%-6.7M

31.37%-5.07M

-40.10%-22.03M

16.75%-2.91M

32.74%-5.31M

-184.06%-6.43M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	59.06%-2.07M	22.56%-16.96M	13.15%-2.46M	47.28%-2.78M	-3.74%-6.66M	31.40%-5.06M	-42.45%-21.9M	17.43%-2.83M	32.40%-5.27M	-193.51%-6.42M
Net income from continuing operations	17.62%-2.19M	75.36%-11.39M	89.69%-1.7M	71.00%-3.53M	63.01%-3.49M	67.20%-2.66M	26.81%-46.21M	55.09%-16.47M	31.15%-12.19M	-142.03%-9.44M
Operating gains losses	99.29%-21K	-839.32%-3.91M	-119.18%-28K	-20,700.00%-412K	---506K	---2.97M	-89.15%529K	--146K	-99.93%2K	----
Depreciation and amortization	-87.50%6K	-92.85%154K	-98.64%7K	-90.79%50K	-91.01%49K	-91.27%48K	9.23%2.15M	-7.21%515K	-0.91%543K	21.11%545K
Deferred tax	200.00%1K	106.62%28K	149.09%27K	100.54%2K	--0	---1K	-70.56%-423K	77.82%-55K	---368K	--0
Other non cash items	-99.67%1K	173.91%17K	-14,550.00%-293K	--0	350.00%9K	1,605.00%301K	-103.67%-23K	-111.76%-2K	-113.04%-3K	-96.97%2K
Change In working capital	1,065.96%454K	-683.07%-4.13M	-174.53%-761K	80.16%-218K	-321.53%-3.11M	92.37%-47K	126.14%709K	197.67%1.02M	74.79%-1.1M	-1.20%1.4M
-Change in receivables	1,995.24%440K	-81.56%125K	2,504.76%547K	-359.14%-482K	-57.61%39K	-94.46%21K	338.73%678K	-96.59%21K	553.66%186K	216.46%92K
-Change in inventory	196.30%320K	60.83%-465K	-693.85%-772K	-11.43%31K	160.22%168K	110.07%108K	-221.68%-1.19M	133.33%130K	107.61%35K	-193.31%-279K
-Change in prepaid assets	87.12%-47K	-115.07%-172K	-64.72%157K	-58.89%141K	-121.43%-105K	-166.42%-365K	1,601.32%1.14M	37.77%445K	359.85%343K	197.22%490K
-Change in payables and accrued expense	-175.29%-259K	-871.65%-3.46M	-238.88%-693K	104.45%69K	-352.14%-3.18M	43.33%344K	135.00%448K	-10.57%499K	57.98%-1.55M	-19.08%1.26M
-Change in other current liabilities	--0	50.94%-182K	--0	95.54%-5K	79.38%-33K	-476.00%-144K	47.23%-371K	79.21%-74K	12.50%-112K	5.33%-160K
-Change in other working capital	----	--17K	--0	--28K	--0	---11K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	59.06%-2.07M	22.56%-16.96M	13.15%-2.46M	47.28%-2.78M	-3.74%-6.66M	31.40%-5.06M	-42.45%-21.9M	17.43%-2.83M	32.40%-5.27M	-193.51%-6.42M
Investing cash flow
Cash flow from continuing investing activities	0	89.13%-10K	0	0	-116.67%-3K	-450.00%-7K	-104.96%-92K	97.42%-79K	62.92%-33K	-99.65%18K
Capital expenditure reported	--0	67.18%-43K	--0	--0	-200.00%-36K	0.00%-7K	62.78%-131K	-17.91%-79K	62.92%-33K	84.42%-12K
Net PPE purchase and sale	----	-15.38%33K	--0	--0	----	----	--39K	--0	--0	--30K
Cash from discontinued investing activities
Investing cash flow	--0	89.13%-10K	--0	--0	-116.67%-3K	-450.00%-7K	-104.96%-92K	97.42%-79K	62.92%-33K	-99.65%18K
Financing cash flow
Cash flow from continuing financing activities	0	461.47%17.57M	755.96%5.46M	-11,366.67%-338K	-9.60%2.25M	10.2M	-90.60%3.13M	638K	100.10%3K	-92.96%2.49M
Net common stock issuance	--0	----	----	----	----	--10.2M	----	----	----	----
Proceeds from stock option exercised by employees	----	66.04%4.14M	413,700.00%4.14M	--0	----	----	-94.59%2.49M	---1K	-98.51%3K	----
Net other financing activities	----	2,002.97%13.44M	--13.78M	---12.79M	----	----	119.76%639K	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	461.47%17.57M	755.96%5.46M	-11,366.67%-338K	-9.60%2.25M	--10.2M	-90.60%3.13M	--638K	100.10%3K	-92.96%2.49M
Net cash flow
Beginning cash position	15.27%4.56M	-82.66%3.96M	-75.20%1.55M	-59.57%4.67M	-41.25%9.08M	-82.66%3.96M	658.73%22.82M	-78.68%6.25M	-71.29%11.54M	694.45%15.46M
Current changes in cash	-140.37%-2.07M	103.20%604K	232.33%3M	41.20%-3.12M	-12.77%-4.42M	169.59%5.13M	-195.37%-18.86M	65.04%-2.27M	51.45%-5.3M	-110.23%-3.92M
Effect of exchange rate changes	-60.00%-8K	--0	130.00%6K	--0	0.00%-1K	-123.81%-5K	-86.21%4K	-233.33%-20K	100.00%4K	85.71%-1K
End cash Position	-72.71%2.48M	15.27%4.56M	15.27%4.56M	-75.20%1.55M	-59.57%4.67M	-41.25%9.08M	-82.66%3.96M	-82.66%3.96M	-78.68%6.25M	-71.29%11.54M
Free cash flow	59.12%-2.07M	22.83%-17M	15.51%-2.46M	47.61%-2.78M	-4.10%-6.7M	31.37%-5.07M	-40.10%-22.03M	16.75%-2.91M	32.74%-5.31M	-184.06%-6.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall